TSVT Wutah bathi EPS kuartalan 2seventy bio

2seventy bio, Inc. (TSVT) attracts top engineers through innovations in CAR-T therapy, offering them autonomy and RSUs. Quarterly EPS growth illustrates the profitability trend, where this metric equals 100.80. However, trade wars and sanctions are hindering the global exchange of medical technologies. The business is currently focusing on the market rollout of Abecma and the optimization of its scientific portfolio to combat oncology.

Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan 2seventy bio (TSVT): kanggo periode 04.07.2022 - 24.05.2025

2seventy bio, Inc (TSVT) - rincian metrik lan laporan keuangan

- rega saham lan prakiraan rega para ahli:

Rega saham 2seventy bio|TSVT - Target konsensus

- data kapitalisasi pasar:

Kapitalisasi pasar 2seventy Bio|TSVT - Total Nilai Perusahaan

- indikator nilai aset resik miturut neraca:

Aset Bersih saben Siji Saham 2seventy bio|TSVT - Nilai Buku Perusahaan|Rasio Nilai Pasar marang Nilai Buku 2seventybio.com|TSVT - Aset Agregat Perusahaan

- data liabilitas lan likuiditas perusahaan:

Rasio Total Utang marang Ekuitas 2seventy bio, Inc.|TSVT - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang modal 2seventy bio, Inc.|TSVT - Tanggungan utang total perusahaan|Utang-utang marang kapitalisasi buku 2seventy Bio|TSVT - Utang jangka dawa|Utang jangka cendhak perusahaan 2seventy bio|Rasio cepet 2seventybio.com

- rincian bathi lan kelipatan pasar:

TSVT - Penghasilan resik perusahaan|Bathi mangsa ngarep 2seventy bio, Inc.|TSVT - Nilai perusahaan marang bathi resik|Prakiraan rega marang bathi 2seventy Bio|TSVT - Rasio nilai perusahaan marang wutah bathi|Pangali EV/EBITDA 2seventy Bio|TSVT - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) 2seventy bio|TSVT - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan 2seventybio.com|TSVT - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep 2seventy bio, Inc.

Analisis fundamental perusahaan:2seventy bio - TSVT

The specifics of 2seventy bio, Inc. (TSVT) gene therapy amid geopolitical risks and logistical disruptions make the quarterly EPS growth rate a key indicator of the business's operational resilience. This metric measures the rate of change in net income per share relative to the previous quarter, allowing investors to assess the actual efficiency of asset capitalization and the company's long-term ability to generate income.

Analisis perusahaan pesaing